Table 1.
Characteristics | Values |
---|---|
N | 147 |
Sex (M/F) | 143/4 (97.3%/2.7%) |
Age (mean, SD) | 54.17 ± 10.87 (19–84) |
Substance use | |
Alcohol consumption | 110 (74.83%) |
Betel-nut consumption | 119 (80.95%) |
Cigarette consumption | 131 (89.16%) |
HNC tumor location | |
Nasopharynx | 3 (2.04%) |
Oral cavity | 98 (66.67%) |
Oropharynx | 17 (11.56%) |
Hypopharynx | 28 (19.05%) |
Larynx | 1 (0.68%) |
Metastatic lesions | |
No | 143 (97.28% |
Yes | 2 (1.36%) |
Unknown | 2 (1.36%) |
Seventh AJCC Staging of the HNSCC | |
Stage I | 20 (13.61%) |
Stage II | 22 (14.97%) |
Stage III | 10 (6.80%) |
Stage IVA | 65 (44.22%) |
Stage IVB | 24 (16.33%) |
Stage IVC | 2 (1.36%) |
Unknown | 4 (2.72%) |
PET/CT scan findings of the esophagus | |
Positive | 8 (5.44%) |
Negative | 139 (94.56%) |
Endoscopic findings | |
Suspicious esophageal lesion | 35 (23.81%) |
Gastric ulcer | 39 (27.08%) |
Duodenal ulcer | 32 (22.07%) |
Pathologic findings in the esophagus | |
Squamous cell carcinoma | 10 (6.80%) |
High-grade dysplasia | 5 (3.40%) |
CLO test positivity | 36 (26.87%) |
AJCC American Joint Committee on Cancer, SD standard deviation, HNSCC head and neck squamous cell carcinoma, CLO Campylobacter-like organism